Tovetumab (MEDI-575), an anti-PDGFRalpha monoclonal antibody, selectively inhibits PDGFRalpha signal transduction. It is utilized in studying glioblastoma and non-small cell lung cancer (NSCLC) [1] [2].
CAS Number:
[1243266-04-7]
* VAT and and shipping costs not included. Errors and price changes excepted